| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 139 |
| 1 | DEXAMETHASONE | 101 |
| 2 | DEXAMETHASONE 1.5 MG | 101 |
| 3 | METHOTREXATE SODIUM | 87 |
| 4 | METHOTREXATE | 78 |
| 5 | MYCOPHENOLATE MOFETIL | 78 |
| 6 | MYCOPHENOLATE MOFETIL HYDROCHLORIDE | 78 |
| 7 | CYCLOPHOSPHAMIDE | 68 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 68 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 68 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOSUNETUZUMAB | 31 | 0.0280 |
| 1 | BENDAMUSTINE HYDROCHLORIDE | 28 | 0.0033 |
| 2 | RITUXIMAB-ABBS | 12 | 0.0024 |
| 3 | TEMOZOLOMIDE | 49 | 0.0023 |
| 4 | CARMUSTINE | 8 | 0.0017 |
| 5 | DONANEMAB-AZBT | 5 | 0.0016 |
| 6 | DACARBAZINE | 12 | 0.0016 |
| 7 | VINCRISTINE SULFATE | 40 | 0.0014 |
| 8 | ATOVAQUONE | 11 | 0.0013 |
| 9 | BLEOMYCIN SULFATE | 12 | 0.0012 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 261 |
| 1 | Alkylating Drug [EPC] | 106 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 87 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 85 |
| 4 | Folate Analog Metabolic Inhibitor [EPC] | 83 |
| 5 | Kinase Inhibitor [EPC] | 77 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 61 |
| 7 | Benzodiazepine [EPC] | 56 |
| 8 | Platinum-based Drug [EPC] | 48 |
| 9 | Microtubule Inhibitor [EPC] | 47 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antileishmanial [EPC] | 2 | 0.0052 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 2 | 0.0016 |
| 2 | Nucleoside Analog Antifungal [EPC] | 2 | 0.0014 |
| 3 | Antimalarial [EPC] | 11 | 0.0011 |
| 4 | Antiprotozoal [EPC] | 11 | 0.0010 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 6 | CD30-directed Immunoconjugate [EPC] | 10 | 0.0010 |
| 7 | Echinocandin Antifungal [EPC] | 7 | 0.0009 |
| 8 | Amyloid Beta-directed Antibody [EPC] | 3 | 0.0008 |
| 9 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 10 | 0.0008 |